X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (14319) 14319
Publication (1308) 1308
Book Review (377) 377
Book Chapter (233) 233
Reference (31) 31
Dissertation (24) 24
Conference Proceeding (18) 18
Magazine Article (11) 11
Book / eBook (7) 7
Data Set (5) 5
Government Document (4) 4
Web Resource (4) 4
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7688) 7688
serotonin reuptake inhibitors (5972) 5972
index medicus (5470) 5470
psychiatry (4937) 4937
male (4809) 4809
pharmacology & pharmacy (4463) 4463
female (4267) 4267
antidepressants (3541) 3541
animals (3165) 3165
neurosciences (3031) 3031
depression (2992) 2992
adult (2845) 2845
serotonin (2337) 2337
double-blind (2134) 2134
fluoxetine (2091) 2091
middle aged (2090) 2090
serotonin uptake inhibitors - therapeutic use (2019) 2019
antidepressive agents - therapeutic use (1842) 1842
clinical neurology (1782) 1782
major depression (1657) 1657
selective serotonin reuptake inhibitors (1655) 1655
rats (1546) 1546
treatment outcome (1462) 1462
aged (1368) 1368
major depressive disorder (1314) 1314
serotonin uptake inhibitors - adverse effects (1261) 1261
serotonin uptake inhibitors - pharmacology (1183) 1183
reuptake inhibitors (1149) 1149
adolescent (1144) 1144
paroxetine (1137) 1137
serotonin uptake inhibitors (1122) 1122
depressive disorder - drug therapy (1110) 1110
antidepressant (1068) 1068
dose-response relationship, drug (1045) 1045
depressive disorder, major - drug therapy (1043) 1043
antidepressive agents - adverse effects (1016) 1016
selective serotonin reuptake inhibitor (967) 967
placebo-controlled trial (954) 954
efficacy (949) 949
analysis (945) 945
obsessive-compulsive disorder (939) 939
drug therapy (918) 918
depression, mental (914) 914
pregnancy (907) 907
anxiety (882) 882
risk factors (880) 880
tricyclic antidepressants (865) 865
depression - drug therapy (851) 851
citalopram (802) 802
mice (801) 801
serotonin-reuptake inhibitors (799) 799
sertraline (788) 788
risk (785) 785
drugs (743) 743
double-blind method (725) 725
antidepressive agents - pharmacology (718) 718
research (712) 712
rats, sprague-dawley (673) 673
serotonin - metabolism (673) 673
care and treatment (659) 659
venlafaxine (638) 638
medicine & public health (637) 637
metaanalysis (634) 634
article (632) 632
drug interactions (631) 631
medicine, general & internal (631) 631
serotonin reuptake inhibitor (631) 631
brain (629) 629
young adult (614) 614
mental depression (612) 612
dopamine (599) 599
serotonin uptake inhibitors - administration & dosage (597) 597
fluvoxamine (594) 594
time factors (581) 581
child (556) 556
psychiatric status rating scales (551) 551
reuptake inhibitor (551) 551
children (542) 542
pharmacotherapy (541) 541
ssri (536) 536
placebo (535) 535
drug therapy, combination (534) 534
health aspects (526) 526
fluoxetine - pharmacology (514) 514
psychology, clinical (514) 514
pharmacology (509) 509
psychology (499) 499
comorbidity (489) 489
pharmacokinetics (486) 486
norepinephrine (484) 484
antidepressive agents, second-generation - therapeutic use (476) 476
prevalence (455) 455
disease models, animal (445) 445
psychopharmacology (445) 445
phenols (442) 442
mental disorders (435) 435
toxicology (434) 434
neurology (428) 428
antidepressant drugs (426) 426
rats, wistar (424) 424
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13888) 13888
German (278) 278
French (159) 159
Spanish (68) 68
Japanese (47) 47
Italian (44) 44
Turkish (39) 39
Russian (30) 30
Portuguese (26) 26
Polish (15) 15
Dutch (13) 13
Korean (13) 13
Czech (8) 8
Chinese (7) 7
Danish (4) 4
Icelandic (4) 4
Hungarian (2) 2
Arabic (1) 1
Croatian (1) 1
Romanian (1) 1
Serbian (1) 1
Slovak (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BBA - General Subjects, ISSN 0304-4165, 11/2017, Volume 1861, Issue 11, pp. 2766 - 2777
Journal Article
Journal Article
Analytical Biochemistry, ISSN 0003-2697, 06/2018, Volume 551, pp. 7 - 18
A simple and sensitive ultrasonic assisted magnetic dispersive solid phase microextraction method (UAMDSPME) coupled with high performance liquid... 
Serotonin–norepinephrine reuptake inhibitor drugs | Ultrasonic assisted magnetic dispersive solid phase microextraction | Experimental design | High performance liquid chromatography | Reduced graphene oxide Quantum Dots nanocomposites | PRECONCENTRATION | GRAPHENE OXIDE | CHEMISTRY, ANALYTICAL | HUMAN PLASMA | BIOCHEMISTRY & MOLECULAR BIOLOGY | BIOCHEMICAL RESEARCH METHODS | NANOMATERIALS | EMPLOYING EXPERIMENTAL-DESIGN | WATER SAMPLES PRIOR | GREEN | PERFORMANCE LIQUID-CHROMATOGRAPHY | EXTRACTION | NANOCOMPOSITE | Serotonin-norepinephrine reuptake inhibitor drugs | Duloxetine Hydrochloride - isolation & purification | Humans | Magnetics | Venlafaxine Hydrochloride - isolation & purification | Atomoxetine Hydrochloride - urine | Serotonin and Noradrenaline Reuptake Inhibitors - isolation & purification | Duloxetine Hydrochloride - urine | Nanocomposites - ultrastructure | Venlafaxine Hydrochloride - analysis | Water Wells | Atomoxetine Hydrochloride - isolation & purification | Serotonin and Noradrenaline Reuptake Inhibitors - urine | Limit of Detection | Microscopy, Electron, Scanning | Solid Phase Microextraction - statistics & numerical data | Serotonin and Noradrenaline Reuptake Inhibitors - analysis | Duloxetine Hydrochloride - analysis | Solid Phase Microextraction - methods | Atomoxetine Hydrochloride - analysis | Venlafaxine Hydrochloride - urine | Water Pollutants, Chemical - analysis | Ultrasonics | Quantum Dots - ultrastructure | Rivers - chemistry | Graphite | Water Supply
Journal Article
Journal of Psychopharmacology, ISSN 0269-8811, 5/2014, Volume 28, Issue 5, pp. 403 - 439
This revision of the 2005 British Association for Psychopharmacology guidelines for the evidence-based pharmacological treatment of anxiety disorders provides... 
treatment | post-traumatic stress disorder | benzodiazepines | separation anxiety disorder | obsessive-compulsive disorder | anxiolytics | evidence-based guidelines | antidepressants | anxiety disorders | serotonin-noradrenaline reuptake inhibitor | Anticonvulsants | selective serotonin reuptake inhibitor | cognitive behaviour therapy | specific phobia | social anxiety disorder | antipsychotics | pregabalin | panic disorder | generalised anxiety disorder | RANDOMIZED CONTROLLED-TRIAL | CLINICAL NEUROLOGY | SEROTONIN REUPTAKE INHIBITORS | RESISTANT PANIC DISORDER | COGNITIVE-BEHAVIORAL THERAPY | PHARMACOLOGY & PHARMACY | PRIMARY-CARE PATIENTS | QUALITY-OF-LIFE | PSYCHIATRY | EVIDENCE-BASED PHARMACOTHERAPY | NEUROSCIENCES | VENLAFAXINE EXTENDED-RELEASE | PLACEBO-CONTROLLED TRIAL | LONG-TERM TREATMENT | Antidepressive Agents - therapeutic use | Decision Making | Evidence-Based Medicine - methods | Delivery of Health Care - methods | Obsessive-Compulsive Disorder - drug therapy | Stress Disorders, Post-Traumatic - drug therapy | Humans | Psychopharmacology - methods | Anxiety Disorders - drug therapy | Practice guidelines (Medicine) | Anxiety | Research | Drug therapy | Analysis | Post-traumatic stress disorder | Practice Guideline | Drug Therapy | Epidemiology | PTSD | Panic Disorder | Phobia | Anxiety Disorders | Treatment | Obsessive-Compulsive Disorder | Psychopharmacology | Evidence Based Treatment | Generalized Anxiety Disorder | Diagnosis
Journal Article